Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Finklea

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Infection and Drug Resistance|October 2, 2018
Multidrug-resistant <i>Pseudomonas aeruginosa</i> from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactamStan D Atkin, Shadaan Abid, Michael Foster, et al.
Antimicrobial Agents and Chemotherapy|December 10, 2024
Cefiderocol pharmacokinetics during acute pulmonary exacerbations in hospitalized adult persons with cystic fibrosisChristina Koenig, Marguerite L Monogue, Ryan K Shields, et al.
Journal of Graduate Medical Education|September 12, 2014
Evaluating Simulation-Based ACLS Education on Patient Outcomes: A Randomized, Controlled Pilot StudyJenny E Han, Antoine R Trammell, James D Finklea, et al.
ERJ Open Research|July 9, 2024
Genomic epidemiology of <i>Mycobacterium abscessus</i> at an adult cystic fibrosis programme reveals low potential for healthcare-associated transmissionJane E Gross, James D Finklea, Silvia M Caceres, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Infection and Drug Resistance|October 2, 2018
Multidrug-resistant <i>Pseudomonas aeruginosa</i> from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactamStan D Atkin, Shadaan Abid, Michael Foster, et al.
Antimicrobial Agents and Chemotherapy|December 10, 2024
Cefiderocol pharmacokinetics during acute pulmonary exacerbations in hospitalized adult persons with cystic fibrosisChristina Koenig, Marguerite L Monogue, Ryan K Shields, et al.
Journal of Graduate Medical Education|September 12, 2014
Evaluating Simulation-Based ACLS Education on Patient Outcomes: A Randomized, Controlled Pilot StudyJenny E Han, Antoine R Trammell, James D Finklea, et al.
ERJ Open Research|July 9, 2024
Genomic epidemiology of <i>Mycobacterium abscessus</i> at an adult cystic fibrosis programme reveals low potential for healthcare-associated transmissionJane E Gross, James D Finklea, Silvia M Caceres, et al.
Pageof 2